MASECO Private Wealth’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-65
Closed -$1.88K 396
2025
Q4
$1.88K Hold
65
﹤0.01% 487
2025
Q3
$1.81K Hold
65
﹤0.01% 234
2025
Q2
$1.58K Buy
+65
New +$1.42K ﹤0.01% 470

Other funds holding ARKG

MASECO Private Wealth's ARKG Position: Q1 2026 in Review

MASECO Private Wealth sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2026, closing a stake of 65 shares — an estimated $1.88K sold.

MASECO Private Wealth first reported a position in ARKG in Q2 2025 and held it in 3 quarters. The position peaked at $1.88K in Q4 2025. 218 funds tracked by Wall St. Rank hold ARKG as of Q1 2026.

  • MASECO Private Wealth reported no remaining ARK Genomic Revolution ETF position as of Q1 2026 after selling out during the quarter.
  • MASECO Private Wealth sold 65 ARK Genomic Revolution ETF shares in Q1 2026, an estimated $1.88K.
  • MASECO Private Wealth first reported a position in ARK Genomic Revolution ETF in Q2 2025 and held it in 3 quarters.
  • MASECO Private Wealth's ARK Genomic Revolution ETF position peaked at $1.88K in Q4 2025.
  • 218 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2026.

Based on MASECO Private Wealth's 13F filing for Q1 2026, filed 21 Apr 2026.